“The US doesn’t pre-approve supplements — doesn’t that make it an easier market?” a capsule-product client opened with. Half right. Under DSHEA, dietary supplements genuinely have no premarket approval: FDA will not review your product before launch. The wrong half: no pre-review does not mean no regulation. FDA moved the enforcement downstream — into manufacturing standards, ingredient legality, label format, and what you dare claim. Pre-approval keeps you out at the door; post-market enforcement takes you down after you are on the shelf. The second one is usually more expensive.
Gate one: cGMP — 21 CFR Part 111
Supplements have their own dedicated cGMP rule (21 CFR Part 111), covering manufacturing, packaging, labeling and holding — the whole chain, so repacking, relabeling and warehousing operations are inside scope, not just the capsule plant. When FDA inspects, or your FSVP importer verifies, Part 111 records are what they read. The three most common fatal findings for Taiwanese makers:
- Missing identity testing: every incoming raw-material lot must be verified to be what it claims; accepting the supplier’s COA without your own testing is the most-cited deficiency
- Incomplete batch records: master and batch production records that do not reconcile — or do not exist
- Label vs formula mismatch: declared ingredients and amounts that cannot be traced to actual batching records
None of these are parking-ticket findings — they are direct grounds for deeming the product adulterated or misbranded.
Gate two: ingredients — NDI notification
DSHEA’s dividing line is October 15, 1994. Dietary ingredients marketed in the US before that date can be used; anything introduced later is an NDI (New Dietary Ingredient) and requires a safety notification filed with FDA 75 days before marketing. The recurring risk in Taiwanese formulas is herbal ingredients and specialty extracts — decades of use in Taiwan does not establish pre-1994 US marketing history. Auditing every ingredient’s status up front is far cheaper than defending it after the goods have shipped.
Gate three: the label — Supplement Facts, not Nutrition Facts
Supplements use the Supplement Facts panel — a different format from the Nutrition Facts panel on conventional food, and the two are not interchangeable; using the wrong panel is itself misbranding. Facility registration (FFR) and per-shipment Prior Notice apply exactly as for conventional food — “no approval needed” does not skip the three gates.
Gate four: claims — and the disclaimer that must ride along
The US permits structure/function claims — “supports immune health” — but they must carry the FDA disclaimer (not evaluated by FDA; not intended to diagnose, treat, cure or prevent any disease), and they must never reach into disease territory. Write “lowers blood pressure” or “treats insomnia” and your supplement just became an unapproved new drug — a different league entirely. Marketing copy and the physical label must be measured with the same ruler.
How SKYCARGO takes it from there
SKYCARGO INC holds FDA and USDA agent status and can act as your Importer of Record and consignee. On supplement projects we run the four gates before shipping: Part 111 documentation readiness, NDI risk across the formula, Supplement Facts layout and claim language — then file Prior Notice and book the freight. On arrival, the same team clears customs, meets any examination, and moves goods into the warehouse and out to channels. Documents we assist with, freight we carry — so “no premarket approval” becomes an actual advantage instead of a trap. Personal-use supplement shipments belong with Shiptw consolidation.
Ready to take a supplement brand into the US? Send us the product format and ingredient list and we will reply within one business day with the gap list across the four gates.
This article summarizes DSHEA and FDA 21 CFR Part 111 requirements for reference only. Confirm specifics against current FDA publications and formal regulatory advice for individual cases.
